CannaPharmaRX, Inc. provided revenue guidance for the full year 2023. For the year, the company expected revenue to be $30 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0109 USD | +9.00% | +9.00% | +541.18% |
16/05 | CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
14/03 | CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+541.18% | 6.54M | |
+39.85% | 723B | |
+34.28% | 595B | |
-3.97% | 369B | |
+20.47% | 332B | |
+2.99% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.02% | 168B |
- Stock Market
- Equities
- CPMD Stock
- News CannaPharmaRX, Inc.
- CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023